PTC Therapeutics
PTCT
#2687
Rank
A$9.38 B
Marketcap
A$116.94
Share price
-0.76%
Change (1 day)
55.84%
Change (1 year)

PTC Therapeutics (PTCT) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$4.23 Billion

According to PTC Therapeutics 's latest financial reports the company's total liabilities are A$4.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

PTC Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$4.50 B13.12%
2023-12-31A$3.98 B32.07%
2022-12-31A$3.01 B12.92%
2021-12-31A$2.67 B18.98%
2020-12-31A$2.24 B52.69%
2019-12-31A$1.47 B34.79%
2018-12-31A$1.09 B262.07%
2017-12-31A$0.30 B45.01%
2016-12-31A$0.20 B8.67%
2015-12-31A$0.19 B350.25%
2014-12-31A$42.46 M146.58%
2013-12-31A$17.22 M-44.54%
2012-12-31A$31.04 M-88.74%
2011-12-31A$0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vertex Pharmaceuticals
VRTX
A$11.41 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.28 B-22.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.16 B-96.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
A$0.37 B-91.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.36 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$94.66 B 2,133.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland